Peritoneal dialysis: Better than, equal to, or worse than hemodialysis? Data worth knowing before choosing a dialysis modality

Peritoneal Dialysis International

Volumn 21, Issue 1, 2001, Pages 25-35

  Thodis, E ^a   Passadakis, P ^a   Vargemezis, V ^a   Oreopoulos, D G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

Author keywords

Adequacy; Comparisons of modalities; Costs; Hemodialysis; Nutrition

Indexed keywords

AMINO ACID; BIOMATERIAL; HEMODIALYSIS FLUID; PERITONEAL DIALYSIS FLUID; PSEUDOMONIC ACID;

BIOCOMPATIBILITY; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; COST CONTROL; DIET THERAPY; DOSE CALCULATION; DYSLIPIDEMIA; ELDERLY CARE; EPIDEMIC; FEMALE; HEALTH CARE COST; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEPATITIS C; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MALNUTRITION; MEDICAL TECHNOLOGY; MORTALITY; PATIENT CARE; PERITONEAL DISEASE; PERITONITIS; PRIORITY JOURNAL; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; SURVIVAL; TREATMENT FAILURE; ULTRAFILTRATION;

EID: 0035054687     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102100105     Document Type: Review

References (87)

1. Peritoneal dialysis: Its indications and contraindications
2. Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: Association with clinical outcomes
3. What really happens to people on long-term peritoneal dialysis?
4. A multi-center, selection adjusted comparison of patient and technique survivals on CAPD and hemodialysis
5. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis
6. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates
7. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis
8. Mortality risks of peritoneal dialysis and hemodialysis
9. Comparative mortality of hemodialysis and peritoneal dialysis in Canada
10. Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting
11. Trends in mortality on peritoneal dialysis: Canada 1981-1997
12. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years
13. Comparison of survival in CAPD and hemodialysis: A multi-center study
14. Peritoneal solute transport predicts survival on CAPD independently of residual renal function
15. Issues affecting the longevity of the continuous peritoneal dialysis therapy
16. A longitudinal five year survey of urea kinetic parameters in CAPD patients
17. Nine patients treated for more than 10 years with continuous ambulatory peritoneal dialysis
18. Survival on chronic peritoneal dialysis: Have results improved in the 1990s?
19. A United Kingdom multicenter study of icodextrin in continuous ambulatory peritoneal dialysis
20. Quality of life and rehabilitation differences among four ESRD therapy groups
21. Sexual and marital relationships and dialysis - Patient's viewpoint
22. Transplantation versus dialysis: A study of quality of life
23. Psychosocial adaptation of CAPD and centre hemodialysis patients
24. Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment
25. Quality of life over time in dialysis: The Netherlands Cooperative Study on the Adequacy of Dialysis
26. The MOS 36-item Shortform Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
27. The SF-36 Health Survey Questionnaire: An outcome measure suitable for routine use within the NHS?
28. Hospitalization: CAPD versus hemodialysis and transplant
29. Excerpts from United States Renal Data System 1996 annual data report: Hospitalization
30. Hospitalization in peritoneal dialysis patients
31. Hospitalization risk in CAPD/CCPD versus hemodialysis (HD) patients by interval Poisson regression
32. Cardiac hospitalization risk in CAPD/CCPD versus hemodialysis patients
33. Residual renal function and recovery of renal function in patients treated by CAPD
34. The influence of dialysis treatment modality on the decline of remaining renal function
35. Is residual renal function better preserved with CAPD than with hemodialysis?
36. Preservation of residual function in maintenance dialysis patients
37. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis
38. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome
39. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity
40. Serum erythropoietin levels and hematocrit in end-stage renal disease: Influence of the mode of therapy
41. Continuous ambulatory peritoneal dialysis: A lesser risk of amyloidosis?
42. B2 microglobulin in CAPD
43. Efficient removal of albumin-bound furancarbolic acid, an inhibitor of erythropoiesis by CAPD
44. Cardiovascular risk factors and blood pressure control in continuous ambulatory peritoneal dialysis
45. Morbidity and mortality of CAPD and hemodialysis
46. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation
47. Left ventricular hypertrophy in end-stage renal disease patients on peritoneal dialysis
48. Effect of increasing intraabdominal pressure and volume on left ventricular function in continuous ambulatory peritoneal dialysis (CAPD)
49. Abdominal diastolic left ventricular filling by pulsed Doppler echocardiography in patients in continuous ambulatory peritoneal dialysis
50. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients. An echocardiographic study
51. Cardiovascular disease in peritoneal dialysis
52. Is an elevated level of serum lipoprotein(a) a risk factor for cardiovascular disease in CAPD patients?
53. Lipoprotein (a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men
54. Multicenter study of lipoprotein (a) and apolipoprotein phenotypes in patients with end stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis
55. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure
56. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution
57. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter site
58. Treatment of malnourished CAPD patients with an amino acid based dialysate
59. Malnutrition, cardiac disease and mortality: An integrated point of view
60. Criteria for selection of ESRD treatment modalities
61. Current status of renal replacement therapy in Japan
62. Renal replacement therapy in the United States: Data from the United States Renal Data System
63. Renal transplantation in patients undergoing chronic peritoneal dialysis
64. The role of peritoneal dialysis as the first line renal replacement modality
65. Dialysis modality and delayed graft function after cadaveric renal transplantation
66. Renal replacement therapies in the elderly: Part II. Renal transplantation
67. Peritoneal dialysis favorably influences recovery of renal function after transplantation
68. Hepatitis C virus infection in dialysis and renal transplantation
69. Incidence of and risk factors for hepatitis B virus infection among hemodialysis and CAPD patients: Evidence for environmental transmission
70. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center
71. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis
72. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: Evaluation of some risk factors
73. AIDS associated nephropathy
74. Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis
75. National surveillance of dialysis associated diseases in the United States, 1993
76. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease
77. Patients with HIV infection and end-stage renal disease
78. Workshop on comparisons of CAPD with hemodialysis and transplantation. The cost of dialysis
79. Treatment costs for peritoneal and hemodialysis therapy in Germany: Results from a prospective cost-comparison analysis approach
80. Analysis and interpretation of cost data in dialysis: Review of Western European literature
81. Options for dialysis providers in a global capitated environment
82. The quality of life of patients with end-stage renal failure
83. Analysis of the reasons for transfer between hemodialysis and peritoneal dialysis and their effect on survivals
84. An evaluation of an integrative care approach for end-stage renal disease patients
85. Technique failure in peritoneal dialysis and its impact on patient survival